Trial intelligence / Profile preview

Tranexamic acid for dental extractions in adults with inherited bleeding disorders

RBR-2jx9r5Phase 3Completed

Sponsor
Hemocentro Unicamp
Start
Mar 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of tranexamic acid in Oral bleeding (2 arms), sponsored by Hemocentro Unicamp. Started Mar 2016; status: completed.

02

Drugs

tranexamic acid
03

Conditions

Oral bleeding

Beyond the preview

Go deeper on RBR-2jx9r5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-2jx9r5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call